4//SEC Filing
Sabatini Brent 4
Accession 0001628280-25-005864
CIK 0001706431other
Filed
Feb 13, 7:00 PM ET
Accepted
Feb 14, 6:41 PM ET
Size
5.1 KB
Accession
0001628280-25-005864
Insider Transaction Report
Form 4
Sabatini Brent
SVP, Chief Accounting Officer
Transactions
- Sale
Common Stock
2025-02-13$9.15/sh−1,562$14,291→ 28,189 total
Footnotes (2)
- [F1]Represents the automatic sale of shares to cover the Issuer's tax withholding and remittance obligation in connection with the vesting of restricted stock units.
- [F2]Reflects ownership after acquisition by the reporting person on November 29, 2024 of 1,312 shares of common stock pursuant to the Issuer's employee stock purchase program.
Documents
Issuer
Vir Biotechnology, Inc.
CIK 0001706431
Entity typeother
Related Parties
1- filerCIK 0002037272
Filing Metadata
- Form type
- 4
- Filed
- Feb 13, 7:00 PM ET
- Accepted
- Feb 14, 6:41 PM ET
- Size
- 5.1 KB